
|
Chapter 58 has been updated by authors Barry D. Nelkin, Ph.D. and Stephen B. Baylin, M.D. Click Here to read the abstract.
DOI Reference Number : http://dx.doi.org/10.1036/ommbid.74
Certain gliomas have somatic mutation in cytosolic isocitrate dehydrogenase 1. Dang et al. have shown that these mutations confer the enzyme the new ability to transform alpha-ketoglutarate in 2-hydroxyglutarate. This metabolite might be oncogenic, although this is not proven yet.
Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009;462:739-744
Philippe Campeau
For the comprehensive coverage of the topics mentioned here, visit the
continually updated online version of the textbook that continues to
define medical genetics:
Click here to sign up for OMMBID updates to be delivered to your email inbox.
Get updates via your favorite
Follow us on Twitter